Skip to content
PubMed This is a summary of 10 peer-reviewed journal articles Updated
Genetics

Symptoms and Development: What to Watch For

At a Glance

Legius syndrome primarily causes skin pigment changes like café-au-lait spots and skinfold freckling, alongside an increased risk for learning disabilities, ADHD, and macrocephaly. Unlike NF1, it does not cause nerve tumors. Early evaluation can help manage developmental challenges.

While Legius syndrome is a “milder” condition than Neurofibromatosis type 1 (NF1) because it lacks tumor risk, it still involves specific physical and neurodevelopmental traits that patients and parents should understand. Being proactive about these symptoms allows you to secure the support needed to thrive in school, at work, and at home [1][2].

Physical Features of Legius Syndrome

The most visible signs of Legius syndrome are pigmentary, meaning they affect the skin’s color. These features are usually the first things a doctor notices:

  • Café-au-lait Macules (CALMs): These are flat, tan-to-brown spots [1]. Affected individuals usually have multiple spots, often appearing in early infancy and sometimes increasing in number during childhood [2]. While these spots do not cause physical health problems, they are highly visible. It is completely normal to feel self-conscious or experience body image challenges as a result. Options like cosmetic camouflage makeup or consultations with a dermatologist can help manage the psychosocial impact.
  • Skinfold Freckling: Small freckles may appear in the armpits or the groin area (axillary and inguinal freckling) [1].
  • Macrocephaly: Many individuals with Legius syndrome have macrocephaly, which is the medical term for a larger-than-average head size [1][3]. While this can be a standard feature of the syndrome, a doctor will monitor head growth over time.
  • Facial Features: Some individuals may have mild, subtle facial characteristics, such as wider-set eyes, which are sometimes described in the medical literature as “Noonan-like” [1].
  • Lipomas: In adulthood, individuals may develop lipomas, which are benign (non-cancerous) fatty lumps under the skin [1][4]. It is crucial to know that these are completely benign and distinct from the dangerous neurofibromas seen in NF1 [4].

Neurodevelopmental and Behavioral Profile

Because Legius syndrome is a RASopathy—a group of conditions caused by changes in the RAS-MAPK cell communication pathway—it can affect how the brain processes information [5][6]. Every person is different, but common patterns include:

Learning and Cognition

Many individuals with Legius syndrome have “heterogeneous” neurodevelopmental manifestations, meaning the symptoms vary widely from person to person [1]. Some may have mild learning disabilities or cognitive impairments that require extra help in school, while others may have no noticeable difficulties [1][7].

ADHD and Behavior

There is an increased risk for Attention-Deficit/Hyperactivity Disorder (ADHD) and challenges with executive function [8]. This often includes difficulties with working memory—the cognitive ability to hold and process information over short periods of time, like remembering a multi-step instruction [8]. Some children may also show social communication challenges that overlap with Autism Spectrum Disorder (ASD) features [5].

Seizure Risk and Epilepsy

When researching neurological conditions, statistics can be frightening. It is important to know that the vast majority of individuals with Legius syndrome (95% to 97%) will never experience seizures [9].

  • Prevalence: Studies suggest a slightly elevated seizure risk in the range of approximately 3% to 5% compared to the general population [9].
  • Prognosis: The good news is that epilepsy in Legius syndrome is generally pharmacoresponsive, meaning it responds well to standard seizure medications [9]. In many cases, these seizures are “self-limited,” meaning the patient may eventually outgrow them [9].

Proactive Steps

Because the neurodevelopmental features can be subtle at first, a proactive approach is highly effective.

  1. Request a Neuropsychological Evaluation: This is a specialized test that looks at how the brain is functioning. It can identify specific areas of struggle, such as processing speed or memory, before they cause significant academic or professional delays.
  2. Monitor for Mild Seizures: Watch for more than just “grand mal” seizures. Some seizures (like absence seizures) look like brief “staring spells” where the person is unresponsive for a few seconds. If you notice these, discuss them with a neurologist [10].
  3. Early Intervention: For children showing delays in speech or motor skills, early intervention services (like physical or occupational therapy) can make a significant difference in long-term outcomes [10].

Back to Home.

Common questions in this guide

What are the physical signs of Legius syndrome?
The most common physical signs are skin pigment changes, including flat, tan-to-brown spots called café-au-lait macules and skinfold freckling. Some individuals may also have a larger-than-average head size and develop benign fatty lumps under the skin in adulthood.
Does Legius syndrome cause learning disabilities?
Yes, individuals with Legius syndrome have an increased risk for learning challenges, ADHD, and difficulties with executive function and working memory. Symptoms vary widely, so a baseline neuropsychological evaluation can help identify specific needs early.
What is the risk of having seizures with Legius syndrome?
The vast majority of people with Legius syndrome, about 95 to 97 percent, will never experience seizures. For the 3 to 5 percent who do, the seizures usually respond well to standard seizure medications and are sometimes outgrown over time.
Does Legius syndrome cause tumors like NF1 does?
No, unlike Neurofibromatosis type 1 (NF1), Legius syndrome lacks the risk for developing neurofibromas or dangerous nerve tumors. Adults may develop benign fatty lumps called lipomas, but these are completely non-cancerous.
How can I manage the café-au-lait spots associated with this condition?
While these spots do not cause physical health problems, they can be highly visible and impact self-esteem. Options for managing them include using cosmetic camouflage makeup or consulting a dermatologist for specialized advice.

Questions to Ask Your Doctor

Curated prompts to bring to your next appointment.

  1. 1.Based on the specific SPRED1 mutation, what is the estimated risk for developing learning disabilities or ADHD?
  2. 2.Should we schedule a baseline neuropsychological evaluation now, or wait until specific challenges arise?
  3. 3.What signs of seizures should I be looking for, and what should I do if I suspect one is occurring?
  4. 4.Since Legius syndrome can sometimes involve macrocephaly, do we need any baseline neuroimaging like an MRI?
  5. 5.Can you refer us to a dermatologist who specializes in cosmetic options for highly visible café-au-lait spots?

Questions For You

Tap a prompt to share your answer — we'll use it plus this page's context to start a tailored conversation.

References

References (10)
  1. 1

    Novel causative variants in Legius syndrome: SPRED1 Genotype spectrum expansion.

    Chelleri C, Brolatti N, De Marco P, et al.

    American journal of medical genetics. Part A 2024; (194(12)):e63824 doi:10.1002/ajmg.a.63824.

    PMID: 39031930
  2. 2

    Legius Syndrome and its Relationship with Neurofibromatosis Type 1.

    Denayer E, Legius E

    Acta dermato-venereologica 2020; (100(7)):adv00093 doi:10.2340/00015555-3429.

    PMID: 32147744
  3. 3

    Lisch nodules and iris mammillations in two siblings with familial legius syndrome.

    Bixel KD, Cano MJ, Johnson DM, et al.

    Clinical case reports 2020; (8(10)):1867-1871 doi:10.1002/ccr3.2861.

    PMID: 33088508
  4. 4

    The RASopathies: Biology, genetics and therapeutic options.

    Longo JF, Carroll SL

    Advances in cancer research 2022; (153()):305-341 doi:10.1016/bs.acr.2021.07.007.

    PMID: 35101235
  5. 5

    MEK inhibition ameliorates social behavior phenotypes in a Spred1 knockout mouse model for RASopathy disorders.

    Borrie SC, Plasschaert E, Callaerts-Vegh Z, et al.

    Molecular autism 2021; (12(1)):53 doi:10.1186/s13229-021-00458-2.

    PMID: 34311771
  6. 6

    Impaired instrumental learning in Spred1-/- mice, a model for a rare RASopathy.

    Borrie SC, Horner AE, Yoshimura A, et al.

    Genes, brain, and behavior 2021; (20(5)):e12727 doi:10.1111/gbb.12727.

    PMID: 33624414
  7. 7

    The first Slovak Legius syndrome patient carrying the SPRED1 gene mutation.

    Sekelska M, Briatkova L, Olcak T, et al.

    General physiology and biophysics 2017; (36(2)):205-210 doi:10.4149/gpb_2016032.

    PMID: 28150585
  8. 8

    Genetic basis of neurofibromatosis type 1 and related conditions, including mosaicism.

    Legius E, Brems H

    Child's nervous system : ChNS : official journal of the International Society for Pediatric Neurosurgery 2020; (36(10)):2285-2295 doi:10.1007/s00381-020-04771-8.

    PMID: 32601904
  9. 9

    Epilepsy in Legius syndrome: Coincidence or causation?

    Medina Lemus A, Boelman C, Myers KA

    American journal of medical genetics. Part A 2024; (194(6)):e63547 doi:10.1002/ajmg.a.63547.

    PMID: 38268057
  10. 10

    Moyamoya syndrome in a child with Legius syndrome: Introducing a cerebral vasculopathy to the SPRED1 phenotype?

    Pabst L, Carroll J, Lo W, Truxal KV

    American journal of medical genetics. Part A 2021; (185(1)):223-227 doi:10.1002/ajmg.a.61921.

    PMID: 33078527

This page explains the physical and cognitive symptoms of Legius syndrome for educational purposes. Always consult your geneticist or pediatrician for professional medical advice and symptom management.

Get notified when new evidence is published on Legius syndrome.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.